On the first Friday of November 2021, American markets reached yet another summit, carried upward by the twin currents of a labor market finding its footing and medicine advancing against a long shadow. The S&P 500 recorded its 64th all-time high of the year as October's payroll figures — 531,000 new jobs — reminded investors that recovery, however uneven, retains its direction. In the background, a pharmaceutical breakthrough and a patient central bank quietly reinforced what markets had already begun to believe: that the worst disruptions of the pandemic era may be giving way to something mo
US stocks hit record highs as robust October jobs data and Pfizer COVID pill fuel rally
The strongest month for job creation since July
Mark
So the jobs number was the main driver here—531,000 jobs in October. That's a real beat on expectations. What does that tell us about where the labor market actually stands?
Mimi
It tells us the recovery is accelerating after a rough patch. September had been disappointing, and there was real concern about whether momentum was fading. October showed that wasn't the case. The Delta wave was easing by then, and employers started hiring more aggressively again. It's the strongest month since July.
Luke
But I want to be careful here. We're comparing to a forecast of 450,000, which is a median estimate. That doesn't mean the market was panicked if we'd hit 450,000. And September was revised upward from 194,000 to 312,000—that's a significant revision. How much confidence should we have in the October number itself?
Mark
Fair point. So Pfizer's pill also moved the market. An 89 percent reduction in severe COVID risk—is that the kind of number that actually changes behavior, or is it more symbolic at this stage?
Mimi
It's both. Symbolically, it signals that we're moving past the acute crisis phase. Practically, if people believe severe illness is less likely, they're more willing to travel, go to restaurants, book cruises. That's why travel stocks rallied so hard. It's not just about the pill itself; it's about what the pill represents—a return to normal.
Luke
Though we should note the pill is still in trial phase. It's not yet approved or available. The market is pricing in a future scenario, not a present reality. And travel stocks have already recovered a lot from their pandemic lows. How much more upside is really there?
Mark
The S&P 500 hit its 64th all-time high this year. That's a remarkable number. Does that mean the market is overheated, or is it just reflecting genuine economic strength?
Mimi
The earnings are real. Bank of America reported 42 percent year-over-year EBITDA growth in the third quarter. That's substantial. And the Fed just signaled patience on rate hikes, which removes a major headwind. The market has reasons to be optimistic.
Luke
But we should separate the earnings strength from the valuation question. Yes, companies are making more money. That doesn't automatically mean stocks are cheap at current prices. And the Fed's "patience" language—that's one statement from one meeting. It's not a guarantee about future policy. Markets are forward-looking, but they're also prone to extrapolating one good quarter into permanent conditions.
Der Puls
- October's job creation surged to 531,000 — well past forecasts and a sharp reversal from two months of disappointing numbers — signaling the employment recovery had regained its footing after the Delta variant's drag.
- Pfizer's announcement of an oral COVID-19 pill with 89% efficacy sent its stock soaring 11% and ignited a broad rally in travel stocks, as investors priced in a world with fewer pandemic-era disruptions.
- The S&P 500 closed at an all-time high for the 64th time this year, the Nasdaq logged ten straight days of gains, and the Dow led major benchmarks — a market moving in rare, synchronized confidence.
- The Federal Reserve's signal of patience on rate hikes, combined with 42% year-over-year earnings growth across reporting companies, gave analysts reason to forecast an unusually strong year-end performance.
- Not every story was triumphant: Peloton shed 34% of its value in a single session, erasing $8 billion in market cap, while a fake press release falsely claiming Kroger would accept bitcoin cash exposed corporations' continued vulnerability to digital misinformation.
On the first Friday of November 2021, American markets reached yet another summit, carried upward by the twin currents of a labor market finding its footing and medicine advancing against a long shadow. The S&P 500 recorded its 64th all-time high of the year as October's payroll figures — 531,000 new jobs — reminded investors that recovery, however uneven, retains its direction. In the background, a pharmaceutical breakthrough and a patient central bank quietly reinforced what markets had already begun to believe: that the worst disruptions of the pandemic era may be giving way to something more durable.
American stock markets closed the week at fresh peaks on Friday, lifted by a stronger-than-expected jobs report and a promising new coronavirus treatment. The S&P 500 marked its 64th all-time high of the year, capping five consecutive sessions of gains — its longest winning streak since August 2020. The Nasdaq extended its own run to ten straight days of advances, while the Dow led among major benchmarks.
The labor market provided the day's first catalyst. October saw 531,000 nonfarm payroll additions, comfortably exceeding the 450,000 economists had forecast and rebounding sharply from September's revised 312,000. It was the strongest month for job creation since July, arriving as the Delta variant's grip on economic activity continued to ease.
Pfizer supplied the second spark. Trial data showed its oral COVID-19 treatment reduced the risk of severe illness by 89 percent, sending the company's shares up as much as 11 percent and triggering rallies across airlines, cruise operators, casinos, and hotel chains — sectors that had long suffered under pandemic uncertainty.
The broader environment remained favorable. With roughly half of third-quarter earnings reported, companies were showing 42 percent year-over-year EBITDA growth. The Federal Reserve had just signaled patience on interest rate increases, easing a key concern for equity investors. Analysts at major firms described the jobs report as a green light for markets, with year-end performance potentially shaping up to be unusually strong.
Among individual stocks, Nvidia extended a two-day surge to 17 percent after Wells Fargo raised its price target citing metaverse growth potential. Peloton, however, suffered its worst single session on record, falling 34 percent and shedding nearly $8 billion in market value after weak quarterly results. In bond markets, the 10-year Treasury yield dipped below 1.5 percent for the first time in a month. Oil climbed after OPEC held to its gradual production increase plan, with West Texas Intermediate rising above $81 per barrel.
The week closed with a reminder of digital markets' fragility: Kroger was forced to deny a fabricated press release claiming it would accept bitcoin cash — a near-identical replay of a hoax that had targeted Walmart just weeks earlier.
The stock market closed out the week at fresh peaks on Friday, riding a wave of better-than-expected employment figures and optimism about a new coronavirus treatment. The S&P 500 marked its 64th all-time high of the year, extending a winning streak that had now lasted five consecutive sessions—the longest run since August 2020. The tech-focused Nasdaq Composite kept pace, notching its tenth straight day of gains, while the Dow Jones Industrial Average led the charge among the major benchmarks.
The labor market showed genuine momentum. October's nonfarm payroll additions reached 531,000 jobs, outpacing the consensus forecast of 450,000 that economists had submitted to Bloomberg. This represented a sharp rebound from September, which had initially been reported as adding 194,000 jobs but was later revised upward to 312,000. The October figure marked the strongest month for job creation since July, arriving as the Delta variant's grip on the economy continued to loosen. For investors, the data suggested the employment recovery was back on track after two months of underwhelming results.
Pharmaceutical giant Pfizer provided a second catalyst. Trial results for its oral COVID-19 treatment showed the pill reduced the risk of severe illness by 89 percent. The announcement sent Pfizer's stock surging as much as 11 percent and ignited a broad rally across travel-related sectors—airlines, casinos, cruise operators, and hotel chains all benefited from the prospect of fewer pandemic-related disruptions to consumer activity.
The broader market backdrop remained supportive. About half of third-quarter earnings had been reported by Friday, revealing 42 percent year-over-year EBITDA growth and a 17 percent quarterly increase, according to Bank of America. The Federal Reserve had signaled "patience" on interest rate increases just days earlier, removing a near-term threat to equity valuations. Peter Essele, head of portfolio management at Commonwealth Financial Network, framed the jobs report as a green light for investors, suggesting that year-end performance could be unusually strong. Mike Loewengart, managing director of investment strategy at E-Trade Financial, noted that equities had held up despite real headwinds—supply-chain bottlenecks and persistent labor shortages—a testament to the strength of corporate earnings.
Individual stocks told their own stories. Nvidia extended a two-day rally to 17 percent after Wells Fargo highlighted potential metaverse-related growth and raised its price target. Peloton, by contrast, collapsed 34 percent in its worst single day, erasing as much as $8 billion in market value following weak quarterly results, though JPMorgan suggested a strong holiday season could drive a 60 percent rebound next year.
Bond markets moved in the opposite direction. The yield on 10-year Treasury notes slipped to 1.446 percent, marking the first close below 1.5 percent in a month. Oil prices climbed as OPEC and its partners stuck to their plan to increase production by 400,000 barrels daily, resisting pressure from President Joe Biden for a larger increase. West Texas Intermediate crude rose 3.15 percent to $81.29 per barrel, while Brent crude gained 2.59 percent to $82.63. Gold added 1.31 percent to $1,814.94 per ounce.
The week also saw a familiar cryptocurrency sideshow. Kroger, the American grocery chain, had to publicly deny a fake press release claiming it would accept bitcoin cash—an echo of a nearly identical hoax that had targeted Walmart in September. The incident underscored the ongoing vulnerability of major corporations to coordinated misinformation campaigns in digital markets.
Bemerkenswerte Zitate
Today's release flashed a green light for investors, signaling that any immediate concerns are unwarranted. The release is an affirmation that the economy is on the right footing.— Peter Essele, head of portfolio management, Commonwealth Financial Network
Equities have been boosted by strong third-quarter earnings despite headwinds such as supply-chain constraints and persistent labor shortages.— Mike Loewengart, managing director of investment strategy, E-Trade Financial
Möchten Sie die ganze Geschichte?
Das Original lesen bei Business Insider India ↗
Economy & Finance